The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IRWD FINANCIAL STATEMENTS

Ironwood Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

IRWDIronwood Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-1 B-500 M0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue389.3 M $Gross Profit388.4 M $ · 100%Operating Income236.1 M $ · 61%Pre-tax Income207.4 M $ · 53%Net Income to Owners129.9 M $ · 33%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue389.3 M $+26.2%
Gross Profit388.4 M $+54.9%
Operating Income236.1 M $+223.0%
EBITDA241.4 M $+148.2%
Net Income to Owners129.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets285.1 M
  • Current Liabilities32.9 M $7%
  • Long-term Liabilities414.1 M $93%

Key Figures

YoY change
Total Assets285.1 M $-16.9%
Total Liabilities447 M $-31.4%
Total Equity-161.8 M $—
Cash & ST Investments79.1 M $-14.8%
Total Debt11.9 M $-98.0%
Net Debt-67.3 M $-113.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M300 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M190.7 M $Operating-1 K $Investing-199.6 M $Financing-8.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow190.7 M $+535.9%
Capital Expenditures3 K $-95.4%
Free Cash Flow190.7 M $+536.9%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IRWD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.